Lalit N Goswami

Title: Lalit N Goswami: Innovator in Neuromuscular Blocking Agents

Introduction

Lalit N Goswami is a prominent inventor based in Columbia, MO (US). He has made significant contributions to the field of pharmacology, particularly in the development of neuromuscular blocking agents. His innovative work has the potential to impact various medical applications.

Latest Patents

Lalit N Goswami holds a patent for neuromuscular blocking agents. The patent discloses carborane derivatives of Formula I or Formula V, or a pharmaceutically acceptable salt thereof, for use as neuromuscular blocking agents. The carborane is substituted with two cationic functional groups selected from amines that form ammonium cations, ethers and/or alcohols that form oxonium cations, sulfides and/or thiols that form sulfonium cations, and phosphanes and/or phosphines that form phosphonium cations. This innovative approach could lead to advancements in medical treatments.

Career Highlights

Lalit N Goswami is affiliated with the University of Missouri, where he conducts research and develops new pharmaceutical agents. His work is characterized by a commitment to advancing medical science and improving patient care through innovative solutions.

Collaborations

Some of his notable coworkers include George R Kracke and Marion Frederick Hawthorne. Their collaborative efforts contribute to the research and development of new therapeutic agents.

Conclusion

Lalit N Goswami's contributions to the field of neuromuscular blocking agents exemplify the importance of innovation in medicine. His work at the University of Missouri continues to pave the way for future advancements in pharmacology.